HFA Premium Access

Registry Updates

Event: Heart Failure 2021 Online Congress
Topic: Chronic Heart Failure
Session type: Registry Session
Date: 29 June 2021
Time: 08:00 - 08:01

Session

11 presentations in this session

SCD and ventricular event rates in a Japanese population: Primary results from the Heart Failure Indication and Sudden Cardiac Death Prevention Trial

Speaker: Doctor K. Aonuma (Tsukuba, JP)
Thumbnail

Clinical course and related costs of patients with type 2 diabetes and heart failure and/or chronic kidney disease, drawn from a sample of more than 7 million people

Speaker: Professor A. Maggioni (Florence, IT)
Thumbnail

Potential Implications of Expanded FDA Labeling for Sacubitril/Valsartan in the United States

Speaker: Doctor M. Vaduganathan (Boston, US)
Thumbnail

Prescription Fill Patterns of Guideline-Directed Medical Therapies for Heart Failure During the COVID-19 Pandemic in the United States

Speaker: Doctor M. Vaduganathan (Boston, US)
Thumbnail

Higher Alkaline Phosphatase Mean and Variability Predict Heart Failure and All-cause Mortality

Speaker: Ms S. Lee (Hong Kong, CN)
Thumbnail

Heart Failure Drug Titration, Discontinuation and Mortality and HF Hospitalization Risk: A Multinational Observational Study (US, UK and Sweden)

Speaker: Associate Professor G. Savarese (Stockholm, SE)
Thumbnail

A comprehensive characterization of acute heart failure with preserved vs. mildly reduced vs. reduced ejection fraction: insights from the ESC-HFA EORP Heart Failure Long-Term Registry

Speaker: Doctor A. Kaplon Cieslicka (Warsaw, PL)
Thumbnail

Eligibility for dapagliflozin and empagliflozin in real-world heart failure based on DAPA-HF, DELIVER, EMPEROR-Reduced and EMPEROR-Preserved selection criteria

Speaker: Associate Professor G. Savarese (Stockholm, SE)
Thumbnail

The risk of all-cause death after COVID-19 hospital admission among patients with prior heart failure, chronic kidney disease and cardiorenal syndrome: a 12 month follow-up observational study

Speaker: Doctor J. Bodegard (Oslo, NO)
Thumbnail

Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs. reduced ejection fraction based on the 2021 definition and classification of heart failure

Speaker: Professor L. Lund (Stockholm, SE)
Thumbnail

11 speakers from this session

Doctor Kazutaka Aonuma

, Tsukuba (Japan)
1 presentation
0 follower

Professor Aldo Pietro Maggioni

ANMCO Research Center, Florence (Italy)
29 presentations
3 followers

Doctor Muthiah Vaduganathan

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
8 presentations
0 follower

Doctor Muthiah Vaduganathan

Brigham And Women'S Hospital, Harvard Medical School, Boston (United States of America)
8 presentations
0 follower

Ms Sharen Lee

The Chinese University of Hong Kong, Hong Kong (China)
1 presentation
0 follower

Associate Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)
16 presentations
0 follower

Doctor Agnieszka Kaplon Cieslicka

Medical University of Warsaw, Warsaw (Poland)
1 presentation
0 follower

Associate Professor Gianluigi Savarese

Karolinska Institute, Stockholm (Sweden)
16 presentations
0 follower

Doctor Johan Bodegard

AstraZeneca, Oslo (Norway)
1 presentation
0 follower

Professor Lars Lund

Karolinska Institute, Stockholm (Sweden)
46 presentations
1 follower

Doctor Carla Plymen

Imperial College Healthcare NHS Trust, London (United Kingdom of Great Britain & Northern Ireland)
4 presentations
0 follower

This platform is supported by

logo Novo Nordisk